Current Protein Identity:P18627 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
7TZG Structure of human LAG3 in complex with antibody single-chain variable fragment Deposited 2022-02-15 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 23–430(408 aa) Fragment:ectodomain
Chain D 23–430(408 aa) Fragment:ectodomain
Mutation:M171I Mutation:M171I NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;1% Tacsimate at pH 5.0, 0.05 M sodium citrate tribasic dihydrate, pH 5.6 and 7% PEG3350
Resolution 3.71 Å R-free 0.275
7TZH Structure of human LAG3 domains 3-4 in complex with antibody single chain-variable fragment Deposited 2022-02-15 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 261–450(190 aa) Fragment:ectodomain
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;0.1 M HEPES pH 7.1, 13% PEG20000
Resolution 2.43 Å R-free 0.255
7TZH Structure of human LAG3 domains 3-4 in complex with antibody single chain-variable fragment Deposited 2022-02-15 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 261–450(190 aa) Fragment:ectodomain
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;0.1 M HEPES pH 7.1, 13% PEG20000
Resolution 2.43 Å R-free 0.255
7UM3 Crystal structure of a Fab in complex with a peptide derived from the LAG-3 D1 domain loop insertion Deposited 2022-04-06 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain B 82–97(16 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Bis-Tris, pH 5.5, 25% PEG3350
Resolution 2.40 Å R-free 0.265
7UM3 Crystal structure of a Fab in complex with a peptide derived from the LAG-3 D1 domain loop insertion Deposited 2022-04-06 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 82–97(16 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Bis-Tris, pH 5.5, 25% PEG3350
Resolution 2.40 Å R-free 0.265
8SO3 CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 Deposited 2023-04-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain D 1–525(525 aa)
Chain X 1–525(525 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.61 Å
8SR0 CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 local refined Deposited 2023-05-05 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain D 1–525(525 aa)
Chain X 1–525(525 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.53 Å
9BF9 Human LAG-3-HLA-DR1 complex Deposited 2024-04-17 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: tetrameric(4) Review required
Chain D 23–429(407 aa)
Not recorded SO4 SULFATE ION × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277.15 K;22% PEG 8000, 0.16M Li2SO4, 0.1M HEPES pH 7.6
Resolution 3.40 Å R-free 0.253